Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing NaN - NaN of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
Has Results
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood

Completed
  • Hematological Malignancy
  • +5 more
  • Cord blood stem cells
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 20, 2021

Acute Myeloid Leukemia, in Relapse, MDS Trial in Australia, United States (CB-5339)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Myelodysplastic Syndromes
  • Scottsdale, Arizona
  • +8 more
May 17, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021

    Quality of Life and Symptoms in Newly Diagnosed Myelodysplastic

    Active, not recruiting
    • Adult
    • Myelodysplastic Syndromes
    • questionnaire administration
    • +3 more
    • New York, New York
    • +52 more
    Dec 21, 2020

    Quality of Life in Older vs. Younger Adult Patients Undergoing

    Completed
    • Myelodysplastic Syndromes
    • Hematopoietic Cell Transplant
    • ePRO survey
    • Stanford, California
    • +5 more
    Nov 30, 2020

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • +2 more
    • Augusta, Georgia
    • +37 more
    Jul 20, 2020

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    Myelofibroses, Acute Myeloid Leukemia, MDS Trial in New York (Combination AZD1775 with AraC, AZD1775 only)

    Terminated
    Has Results
    • Myelofibroses
    • +2 more
    • Combination AZD1775 with AraC
    • AZD1775 only
    • New York, New York
      NYU Langone Health
    May 20, 2020

    MDS Trial in Boston, New York (Tipifarnib)

    Terminated
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2020

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Withdrawn
    • Leukemia
    • +4 more
    • alemtuzumab
    • +6 more
    • La Jolla, California
    • +23 more
    Nov 25, 2019

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    MDS Trial in Worldwide (Azacitidine, Physician Choice)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Birmingham, Alabama
    • +107 more
    Oct 16, 2019

    Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New York, New York
    • +4 more
    Oct 22, 2018

    Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)

    Terminated
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Phoenix, Arizona
    • +5 more
    Oct 17, 2018

    Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)

    Completed
    • Acute Myelocytic Leukemia
    • +4 more
    • ON 01910.Na
    • New York, New York
      Mount Sinai Medical Center
    Jan 9, 2018

    Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +1 more
    Dec 7, 2017

    Beta-thalassemia, MDS, Fanconi Syndrome Trial in United States (Deferasirox)

    Completed
    • Beta-thalassemia
    • +4 more
    • Oakland, California
    • +5 more
    Aug 17, 2017